Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16689 | 28242789 | J Lipid Res | TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD. | 2017 | Details |
| A16690 | 28241825 | BMC Med | Non-alcoholic fatty liver disease. | 2017 | Details |
| A16691 | 28241817 | BMC Endocr Disord | Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease. | 2017 | Details |
| A16695 | 28239403 | Nutr Metab (Lond) | Lipid overload during gestation and lactation can independently alter lipid homeostasis in offspring and promote metabolic impairment after new challenge to high-fat diet. | 2017 | Details |
| A16701 | 28235154 | Liver Int | Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study. | 2017 | Details |
| A16703 | 28233740 | Ann Hepatol | Hepatitis B and NAFLD: Lives Crossed. | 2017 | Details |
| A16705 | 28232481 | FASEB J | Hepatic DsbA-L protects mice from diet-induced hepatosteatosis and insulin resistance. | 2017 | Details |
| A16706 | 28232454 | Am J Physiol Gastrointest Liver Physiol | A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition. | 2017 | Details |
| A16707 | 28231800 | Lipids Health Dis | Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice. | 2017 | Details |
| A16709 | 28231052 | Acta Pharm | Review. The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease. | 2017 | Details |
| A16717 | 28225186 | Aliment Pharmacol Ther | Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A16724 | 28222828 | Nutr Res Rev | Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. | 2017 | Details |
| A16727 | 28220495 | J Pharm Pharmacol | Influence of hyperglycemia on liver inflammatory conditions in the early phase of non-alcoholic fatty liver disease in mice. | 2017 | Details |
| A16731 | 28218919 | Nat Med | Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates. | 2017 | Details |
| A16733 | 28218263 | Nat Rev Nephrol | Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. | 2017 | Details |
| A16741 | 28214020 | J Hepatol | Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents. | 2017 | Details |
| A16744 | 28212710 | Adv Clin Chem | CTRP1 in Liver Disease. | 2016 | Details |
| A16750 | 28211103 | J Neuroendocrinol | Impaired learning and memory in rats induced by a high-fat diet: Involvement with the imbalance of nesfatin-1 abundance and copine 6 expression. | 2017 | Details |
| A16751 | 28210913 | Int Urol Nephrol | Dietary and commercialized fructose: Sweet or sour? | 2017 | Details |
| A16752 | 28209760 | Diabetes | Glucoraphanin Ameliorates Obesity and Insulin Resistance Through Adipose Tissue Browning and Reduction of Metabolic Endotoxemia in Mice. | 2017 | Details |
| A16756 | 28205519 | Nat Commun | Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance. | 2017 | Details |
| A16757 | 28203453 | Iran Red Crescent Med J | Association of Osteoprotegerin with Obesity, Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Children. | 2016 | Details |
| A16758 | 28202906 | Sci Rep | BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis. | 2017 | Details |
| A16762 | 28195199 | Sci Rep | Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis. | 2017 | Details |
| A16763 | 28195177 | Am J Gastroenterol | Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data. | 2017 | Details |
| A16764 | 28194671 | Dig Dis Sci | Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis. | 2017 | Details |
| A16769 | 28192110 | Gastroenterology | Risk of Obesity-Related Cardiometabolic Complications in Special Populations: A Crisis in Asians. | 2017 | Details |
| A16775 | 28185191 | Methods Mol Biol | A Coupled Approach Utilizing Immunohistochemistry and Immunocytochemistry to Visualize Cellular Lipophagy. | 2017 | Details |
| A16776 | 28184213 | Front Endocrinol (Lausanne) | Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16780 | 28181781 | Minerva Endocrinol | Thyroid dysfunction and non-alcoholic fatty liver disease. | 2017 | Details |
| A16781 | 28180059 | Mol Metab | JNK at the crossroad of obesity, insulin resistance, and cell stress response. | 2016 | Details |
| A16783 | 28179090 | Dig Liver Dis | Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A16788 | 28177674 | Can J Physiol Pharmacol | Exercise restores bioavailability of hydrogen sulfide and promotes autophagy influx in livers of mice fed with high-fat diet. | 2017 | Details |
| A16804 | 28163820 | Oxid Med Cell Longev | Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death. | 2017 | Details |
| A16805 | 28163011 | Obes Res Clin Pract | Aerobic endurance training improves nonalcoholic fatty liver disease (NAFLD) features via miR-33 dependent autophagy induction in high fat diet fed mice. | 2017 | Details |
| A16811 | 28159867 | J Lipid Res | Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine N-methyltransferase. | 2017 | Details |
| A16815 | 28157387 | Can J Physiol Pharmacol | Trigonelline attenuates hepatic complications and molecular alterations in high-fat high-fructose diet-induced insulin resistance in rats. | 2016 | Details |
| A16816 | 28155627 | Curr Vasc Pharmacol | Surrogates of Insulin Sensitivity and Indices of Cardiometabolic Profile in Obesity. | 2017 | Details |
| A16817 | 28155087 | Curr Gastroenterol Rep | The Association Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16819 | 28153708 | Biochim Biophys Acta Mol Basis Dis | Steroidogenic acute regulatory protein (StAR) overexpression attenuates HFD-induced hepatic steatosis and insulin resistance. | 2017 | Details |
| A16822 | 28149843 | Ann Transl Med | Gamma-glutamyl transferase and cardiovascular disease. | 2016 | Details |
| A16825 | 28146130 | Nutrients | Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD). | 2017 | Details |
| A16827 | 28144388 | World J Hepatol | Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade. | 2017 | Details |
| A16830 | 28142230 | Korean J Intern Med | Compound K attenuates glucose intolerance and hepatic steatosis through AMPK-dependent pathways in type 2 diabetic OLETF rats. | 2017 | Details |
| A16832 | 28139562 | Ter Arkh | [The informative value of non-invasive liver fibrosis markers in patients with nonalcoholic fatty liver disease]. | 2017 | Details |
| A16833 | 28139281 | Clin Nutr | Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. | 2017 | Details |
| A16834 | 28139128 | Vnitr Lek | [Coffee as hepatoprotective factor]. | 2017 | Details |
| A16839 | 28133993 | Appl Physiol Nutr Metab | A "healthy diet-optimal sleep" lifestyle pattern is inversely associated with liver stiffness and insulin resistance in patients with nonalcoholic fatty liver disease. | 2016 | Details |
| A16845 | 30539079 | Sports Med Int Open | Simple Resistance Exercise for 24 Weeks Decreases Alanine Aminotransferase Levels in Patients with Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16851 | 28127194 | World J Gastroenterol | Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease. | 2017 | Details |
| A16855 | 28125073 | Clin Transl Gastroenterol | The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16856 | 28125040 | Molecules | Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. | 2017 | Details |
| A16861 | 28123944 | Mol Metab | Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1. | 2016 | Details |
| A16862 | 28123936 | Mol Metab | Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism. | 2016 | Details |
| A16866 | 28120721 | Curr Pharm Des | Progranulin, a New Adipokine at the Crossroads of Metabolic Syndrome, Diabetes, Dyslipidemia and Hypertension. | 2017 | Details |
| A16867 | 28120165 | J Inherit Metab Dis | Investigating the link of ACAD10 deficiency to type 2 diabetes mellitus. | 2017 | Details |
| A16868 | 28119530 | Int J Obes (Lond) | Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD. | 2017 | Details |
| A16870 | 28116873 | Endocrinol Metab (Seoul) | The SCAP/SREBP Pathway: A Mediator of Hepatic Steatosis. | 2017 | Details |
| A16872 | 28116779 | Mol Nutr Food Res | Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet-induced obesity. | 2017 | Details |
| A16876 | 28115523 | J Biol Chem | APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice. | 2017 | Details |
| A16879 | 28112684 | J Clin Invest | Out of the frying pan: dietary saturated fat influences nonalcoholic fatty liver disease. | 2017 | Details |
| A16880 | 28112681 | J Clin Invest | Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance. | 2017 | Details |
| A16882 | 28112071 | J Dev Orig Health Dis | Early life programming and the risk of non-alcoholic fatty liver disease. | 2017 | Details |
| A16888 | 28109892 | Free Radic Biol Med | Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis. | 2017 | Details |
| A16889 | 28109166 | Br J Pharmacol | A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference. | 2017 | Details |
| A16895 | 28107283 | J Pediatr Gastroenterol Nutr | NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). | 2017 | Details |
| A16897 | 28106137 | Sci Rep | Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats. | 2017 | Details |
| A16898 | 28105511 | Calcif Tissue Int | Bone Density in the Obese Child: Clinical Considerations and Diagnostic Challenges. | 2017 | Details |
| A16899 | 28104990 | World J Gastroenterol | Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial. | 2017 | Details |
| A16901 | 28103934 | Lipids Health Dis | The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. | 2017 | Details |
| A16907 | 28100008 | Hepatology | Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review. | 2017 | Details |
| A16910 | 28098910 | Mol Med Rep | Hydrogen-rich saline improves non‑alcoholic fatty liver disease by alleviating oxidative stress and activating hepatic PPARα and PPARγ. | 2017 | Details |
| A16912 | 28098578 | J Clin Gastroenterol | Helicobacter pylori and Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. | 2019 | Details |
| A16925 | 28089623 | Dig Liver Dis | Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? | 2016 | Details |
| A16935 | 28084795 | Appl Physiol Nutr Metab | Moderate physical activity promotes basal hepatic autophagy in diet-induced obese mice. | 2016 | Details |
| A16940 | 28082742 | Exp Mol Med | Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes. | 2017 | Details |
| A16942 | 28081780 | Metabolism | Association between vascular inflammation and non-alcoholic fatty liver disease: Analysis by 18F-fluorodeoxyglucose positron emission tomography. | 2016 | Details |
| A16948 | 28077863 | Int J Obes (Lond) | What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications? | 2017 | Details |
| A16952 | 28076482 | Arq Bras Cir Dig | CORRELATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND FEATURES OF METABOLIC SYNDROME IN MORBIDLY OBESE PATIENTS IN THE PREOPERATIVE ASSESSMENT FOR BARIATRIC SURGERY. | 2017 | Details |
| A16953 | 28076416 | PLoS One | The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis. | 2017 | Details |
| A16971 | 28069746 | Postgrad Med J | Non-alcoholic fatty pancreas disease. | 2017 | Details |
| A16981 | 28064013 | J Nutr Biochem | Changes in liver proteins of rats fed standard and high-fat and sucrose diets induced by fish omega-3 PUFAs and their combination with grape polyphenols according to quantitative proteomics. | 2016 | Details |
| A16982 | 28064001 | Biochim Biophys Acta Mol Cell Res | Endoplasmic reticulum-mitochondria calcium signaling in hepatic metabolic diseases. | 2017 | Details |
| A16984 | 28063505 | Nutrition | Alternative treatment methods attenuate the development of NAFLD: A review of resveratrol molecular mechanisms and clinical trials. | 2016 | Details |
| A16987 | 28062946 | J Gastroenterol | Upregulated absorption of dietary palmitic acids with changes in intestinal transporters in non-alcoholic steatohepatitis (NASH). | 2017 | Details |
| A16993 | 28058076 | Gastroenterology Res | Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature. | 2016 | Details |
| A16996 | 28053786 | Int J Hepatol | Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A16998 | 28053680 | Prz Gastroenterol | Reduction of sitting time has a positive effect on the decrease of insulin resistance in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A17001 | 28053201 | Br J Sports Med | Evidence that supports the prescription of low-carbohydrate high-fat diets: a narrative review. | 2017 | Details |
| A17011 | 28051126 | Sci Rep | Cytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis. | 2017 | Details |
| A17027 | 31509653 | Klin Lab Diagn | [The cognitive biological function, difference in etiology and generality of pathogenesis of metabolic pandemics. The metabolism regulation in carnivorous and herbivorous animals under effect of environment factors.] | 2017 | Details |
| A17028 | 30802390 | Klin Lab Diagn | [The phylogenetic theory of general pathology. The development of seven biological functions, seven specific ones and etiological factors of metabolic epidemics, millions years' common pathogenesis and basics of prevention.] | 2019 | Details |
| A17032 | 29911800 | Yao Xue Xue Bao | [Protective effect and underlying mechanism of cordycepin on non-alcoholic fatty liver in ob/ob mice]. | 2017 | Details |
| A17038 | 28036028 | Nutrients | Application of an In Vivo Hepatic Triacylglycerol Production Method in the Setting of a High-Fat Diet in Mice. | 2016 | Details |
| A17039 | 28035771 | Hepatology | Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study. | 2016 | Details |
| A17044 | 28032449 | Diabetes Metab Res Rev | Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes. | 2017 | Details |
| A17045 | 28030556 | PLoS One | Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17047 | 28029021 | Endocrinol Metab (Seoul) | Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17048 | 28028821 | Aliment Pharmacol Ther | Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A17051 | 28027934 | Biochem Biophys Res Commun | Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD. | 2016 | Details |